Health Canada drug identification number

DIN 00886963 — CEFTAZIDIME FOR INJECTION, USP 6 G

CEFTAZIDIME FOR INJECTION, USP is a powder for solution of Ceftazidime marketed by FRESENIUS KABI CANADA LTD. The full Ceftazidime monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00886963
Brand name
CEFTAZIDIME FOR INJECTION, USP
Active ingredient
Ceftazidime
Strength
6 G
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
FRESENIUS KABI CANADA LTD
Health Canada status
MARKETED
Drug class
Third-generation cephalosporin antibiotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ceftazidime products

DINBrandStrengthFormManufacturerStatus
02437848 CEFTAZIDIME FOR INJECTION BP 1 G POWDER FOR SOLUTION STERIMAX INC MARKETED
02437856 CEFTAZIDIME FOR INJECTION BP 2 G POWDER FOR SOLUTION STERIMAX INC MARKETED
02437864 CEFTAZIDIME FOR INJECTION BP 6 G POWDER FOR SOLUTION STERIMAX INC MARKETED
02439522 CEFTAZIDIME FOR INJECTION, BP 3 G POWDER FOR SOLUTION STERIMAX INC DORMANT
00886971 CEFTAZIDIME FOR INJECTION, USP 1 G POWDER FOR SOLUTION FRESENIUS KABI CANADA LTD MARKETED
00886955 CEFTAZIDIME FOR INJECTION, USP 2 G POWDER FOR SOLUTION FRESENIUS KABI CANADA LTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.